SXTP.NASDAQ60 Degrees Pharmaceuticals, INC

Form 4: Stephen Toovey, Director at 60 Degrees Pharmaceuticals, Settles Restricted Stock Units

Sentiment:

SEC Form 4

📋All filings for 60 Degrees Pharmaceuticals, INC
🔒Login to Follow

Director Stephen Toovey settles restricted stock units for common stock in 60 Degrees Pharmaceuticals.

Summary

  • Stephen Toovey, a director at 60 Degrees Pharmaceuticals, settled 4,000 restricted stock units (RSUs) for common stock on May 16, 2024.
  • The transaction resulted in Toovey acquiring 4,000 shares of common stock at a price of $0.223 per share.
  • Following the transaction, Toovey's direct ownership of common stock increased, and he no longer holds any RSUs.
  • Initially, Toovey was granted 8,000 RSUs on July 11, 2023, which were subsequently modified to 4,000 RSUs fully vested as of December 31, 2023.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.

Key Dates

DateDescription
07/11/2023Stephen Toovey was initially granted 8,000 restricted stock units.
12/31/2023Modification of RSUs to 4,000 fully vested RSUs.
12/31/2023Date of earliest transaction.
05/16/2024Settlement of 4,000 restricted stock units for common stock.
05/21/2024Date of Form 4 filing.

Keywords

Stephen Toovey, 60 Degrees Pharmaceuticals, Director, Restricted Stock Units, Common Stock, Settlement, Ownership, SXTP

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.